Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for CorMedix Inc. Common stock, $0.001 par value (CRMD).
- Disclosed ownership: 6.3%.
- Date of event: 21 Nov 2025.
Deep Track Capital, LP - 21 Nov 2025 SCHEDULE 13G Report for CorMedix Inc. Common stock, $0.001 par value (CRMD)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- CRMD
- Shares outstanding
- 78,783,577 shares
- Disclosed Ownership
- 4,955,487 shares
- Ownership
- 6.3%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Dec 2025, 16:28:19 UTC
- Date of event
- 21 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 6.3% ownership in CorMedix Inc. Common stock, $0.001 par value (CRMD) on 21 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 01 Dec 2025, 16:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 6.3% | 4,955,487 | 0 | 4,955,487 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 6.3% | 4,955,487 | 0 | 4,955,487 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 6.3% | 4,955,487 | 0 | 4,955,487 | /s/ David Kroin | David Kroin |